Endoscopic and Mucosal Healing in Crohn’s Disease with Azathioprine

 Mucosal healing is one of the main aims of therapy in Crohn’s disease. Although, mucosal healing with Azathioprine has been reported in some studies before with low rates, anti- tumor necrosis factor (TNF) antibodies are more commonly associated with mucosal healing. However, it is clear that anti-TNF antibodies are more expensive with more common adverse events and with the lack of long term results. Herein we will report endoscopic and mucosal healing in 2 years period with Azathiopurine treatment in a young patient with Crohn’s disease.